Our results tend to support these overall findings of reliable remodelling of DBM to new bone. The histological analysis showed significant new bone formation and decreasing residual DBM material in ...

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced it has entered into a supplier agreement with Vizient, the nation's ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel synthetic bone graft showed noninferiority to ...

Over 400,000 spinal fusion surgeries are performed annually in the United States and as the population ages, that number is expected to rise. The goal of many spinal fusion surgeries is to reduce or ...

A research team from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine at ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that ...

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal ...

A research team from the Department of Orthopedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), has developed a titanium implant ...

This clinical trial is designed to demonstrate that TETRANITE® can immediately fixate cranial flaps and enable bone fusion in craniotomy and cranioplasty procedures to improve cosmesis, increase flap ...